New Key Statistics Module, Z-Score and F-Score
NAS:FDMT Key Ratios
| Market Cap $ M | 255.18 |
| Enterprise Value $ M | -221.88 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.52 |
| Price/Sales | 5,520.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -2.85 |
| Beneish M-Score | -271.35 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -16.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 1.32 |
| EV-to-EBITDA | 1.37 |
| PEG | -- |
| Shares Outstanding M | 46.23 |
| Net Margin (%) | -844,000.00 |
| Operating Margin % | -990,447.06 |
| Pre-tax Margin (%) | -844,000.00 |
| Quick Ratio | 17.33 |
| Current Ratio | 17.33 |
| ROA % (ttm) | -28.07 |
| ROE % (ttm) | -30.15 |
| ROIC % (ttm) | -240.61 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.95 |
FDMT Number of Guru Trades
FDMT Volume of Guru Trades
Gurus Latest Trades with NAS:FDMT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FDMT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
4D Molecular Therapeutics Inc Insider Transactions
No Available Data
News about NAS:FDMT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers